The phospho-ERK1/2 levels are reduced in PCOS granulosa cells [22], whereas the MAPK/ERK signaling pathway is hyperactive in the PCOS endometrium [23]. This evidence concerns the gene MAPK3 and polycystic ovary syndrome.